Original Research

Published on 16 Jan 2024

Prediction of antigen-responding VHH antibodies by tracking the evolution of antibody along the time course of immunization

in Vaccines and Molecular Therapeutics

Tomonari Matsuda
Yoko Akazawa-Ogawa
Lilian-Kaede Komaba
Norihiko Kiyose
Nobuo Miyazaki
Yusaku Mizuguchi
Tetsuo Fukuta
Yuji Ito
Yoshihisa Hagihara

Frontiers in Immunology

doi 10.3389/fimmu.2023.1335462

2,766 views

Original Research

Published on 12 Jan 2024

Immunogenicity and efficacy of an oral live-attenuated vaccine for bovine Johne’s disease

in Vaccines and Molecular Therapeutics

Razieh Eshraghisamani
Antonio Facciuolo
Victoria Harman-McKenna
Oscar Illanes
Jeroen De Buck

Frontiers in Immunology

doi 10.3389/fimmu.2023.1307621

2,195 views
2 citations

Original Research

Published on 09 Jan 2024

A candidate glycoconjugate vaccine induces protective antibodies in the serum and intestinal secretions, antibody recall response and memory T cells and protects against both typhoidal and non-typhoidal Salmonella serovars

in Vaccines and Molecular Therapeutics

Risha Haldar
Amlanjyoti Dhar
Debayan Ganguli
Suparna Chakraborty
Ananda Pal
George Banik
Shin-ichi Miyoshi
Santasabuj Das

Frontiers in Immunology

doi 10.3389/fimmu.2023.1304170

2,748 views
3 citations

Original Research

Published on 09 Jan 2024

Association between immune checkpoint inhibitor medication and uveitis: a population-based cohort study utilizing TriNetX database

in Vaccines and Molecular Therapeutics

Hou-Ting Kuo
Chia-Yun Chen
Alan Y. Hsu
Yu-Hsun Wang
Chun-Ju Lin
Ning-Yi Hsia
Yi-Yu Tsai
James Cheng-Chung Wei

Frontiers in Immunology

doi 10.3389/fimmu.2023.1302293

4,263 views
6 citations

Review

Published on 08 Jan 2024

Impact of structural modifications of IgG antibodies on effector functions

in Vaccines and Molecular Therapeutics

Timon Damelang
Maximilian Brinkhaus
Thijs L. J. van Osch
Janine Schuurman
Aran F. Labrijn
Theo Rispens
Gestur Vidarsson

Frontiers in Immunology

doi 10.3389/fimmu.2023.1304365

20,382 views
19 citations

Original Research

Published on 08 Jan 2024

Transmission characteristics and inactivated vaccine effectiveness against transmission of the SARS-CoV-2 Omicron BA.2 variant in Shenzhen, China

in Vaccines and Molecular Therapeutics

Xiaofeng He
Yuxue Liao
Yuanhao Liang
Jiexin Yu
Wei Gao
Jia Wan
Yi Liao
Jiao Su
Xuan Zou
Shixing Tang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1290279

1,371 views
1 citation

Original Research

Published on 05 Jan 2024

Immunogenicity, safety and consistency of seven lots of an inactivated COVID-19 vaccine in healthy children and adolescents: a randomized, double-blind, controlled, phase IV clinical trial

in Vaccines and Molecular Therapeutics

Weijun Hu
Xiaoyu Liu
Xi Lu
Dan Zhang
Shuo Liu
Xianjin Gu
Dan Liu
Jianwen Sun
Tiantian Zhou
Xinge Li

Frontiers in Immunology

doi 10.3389/fimmu.2023.1320352

2,060 views

Original Research

Published on 04 Jan 2024

Humoral and cell-mediated immune responses in HIV-vertically infected young patients after three doses of the BNT162b2 mRNA SARS-CoV-2 vaccine

in Vaccines and Molecular Therapeutics

Claudia Vanetti
Marta Stracuzzi
Elisa Crivellaro
Federica Ciciliano
Micaela Garziano
Claudio Fenizia
Mara Biasin
Valeria Rubinacci
Antonella Amendola
Elisabetta Tanzi

Frontiers in Immunology

doi 10.3389/fimmu.2023.1301766

1,537 views

Original Research

Published on 04 Jan 2024

Humoral and cellular immune responses after COVID-19 vaccination of lung transplant recipients and patients on the waiting list: a 6-month follow-up

in Vaccines and Molecular Therapeutics

Rogier A. S. Hoek
Siqi Liu
Corine H. GeurtsvanKessel
Erik A. M. Verschuuren
Judith M. Vonk
Merel E. Hellemons
Mirjam Kool
Nynke Wijbenga
Susanne Bogers
Sandra Scherbeijn

Frontiers in Immunology

doi 10.3389/fimmu.2023.1254659

1,784 views
1 citation

Original Research

Published on 03 Jan 2024

Refined innate plasma signature after rVSVΔG-ZEBOV-GP immunization is shared among adult cohorts in Europe and North America

in Vaccines and Molecular Therapeutics

Paola Andrea Martinez-Murillo
Angela Huttner
Sylvain Lemeille
Donata Medaglini
Tom H. M. Ottenhoff
Ali M. Harandi
Arnaud M. Didierlaurent
Claire-Anne Siegrist

Frontiers in Immunology

doi 10.3389/fimmu.2023.1279003

1,784 views
1 citation

Systematic Review

Published on 21 Dec 2023

Evaluation of the efficacy, safety and influencing factors of concomitant and sequential administration of viral respiratory infectious disease vaccines: a systematic review and meta-analysis

in Vaccines and Molecular Therapeutics

Dafeng Lu
Yifang Han
Ruowei Xu
Mingke Qin
Jianwei Shi
Caihong Zhang
Jinhai Zhang
Fuqiang Ye
Zhenghan Luo
Yuhe Wang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1259399

2,468 views

Original Research

Published on 20 Dec 2023

Contribution of SARS-CoV-2 infection preceding COVID-19 mRNA vaccination to generation of cellular and humoral immune responses in children

in Vaccines and Molecular Therapeutics

Marije K. Verheul
Martijn Vos
Lia de Rond
Mary-Lène De Zeeuw-Brouwer
Kim H. Nijhof
Debbie Smit
Debbie Oomen
Petra Molenaar
Marjan Bogaard
Rianne van Bergen

Frontiers in Immunology

doi 10.3389/fimmu.2023.1327875

2,138 views
2 citations

Original Research

Published on 20 Dec 2023

Evaluation of the humoral and mucosal immune response of a multiepitope vaccine against COVID-19 in pigs

in Vaccines and Molecular Therapeutics

Juan Mosqueda
Diego Josimar Hernández-Silva
Marco Antonio Vega-López
Lineth J. Vega-Rojas
Rolando Beltrán
Andrés Velasco-Elizondo
María del Carmen Ramírez-Estudillo
Mario Fragoso-Saavedra
Chyntia Pérez-Almeida
Jesús Hernández

Frontiers in Immunology

doi 10.3389/fimmu.2023.1276950

2,727 views

Study Protocol

Published on 20 Dec 2023

The PRotective Effect of Maternal Immunisation on preTerm birth: characterising the Underlying mechanisms and Role in newborn immune function: the PREMITUR study protocol

in Vaccines and Molecular Therapeutics

Michelle L. Giles
Stephen Cole
Jessica O’Bryan
Sushena Krishnaswamy
Rym Ben-Othman
Nelly Amenyogbe
Mary-Ann Davey
Tobias Kollmann

Frontiers in Immunology

doi 10.3389/fimmu.2023.1212320

1,430 views

Original Research

Published on 20 Dec 2023

Appearance of tolerance-induction and non-inflammatory SARS-CoV-2 spike-specific IgG4 antibodies after COVID-19 booster vaccinations

in Vaccines and Molecular Therapeutics

Marjahan Akhtar
Md. Rashedul Islam
Fatema Khaton
Umma Hany Soltana
Syeda Anoushka Jafrin
Sadia Isfat Ara Rahman
Imam Tauheed
Tasnuva Ahmed
Ishtiakul Islam Khan
Afroza Akter

Frontiers in Immunology

doi 10.3389/fimmu.2023.1309997

7,078 views
9 citations

Original Research

Published on 19 Dec 2023

Non-glycosylated G protein with CpG ODN provides robust protection against respiratory syncytial virus without inducing eosinophilia

in Vaccines and Molecular Therapeutics

Eigo Kawahara
Takehiko Shibata
Toshiro Hirai
Yasuo Yoshioka

Frontiers in Immunology

doi 10.3389/fimmu.2023.1282016

3,006 views
3 citations

Navigation group

Articles

Prediction of antigen-responding VHH antibodies by tracking the evolution of antibody along the time course of immunization

Immunogenicity and efficacy of an oral live-attenuated vaccine for bovine Johne’s disease

A candidate glycoconjugate vaccine induces protective antibodies in the serum and intestinal secretions, antibody recall response and memory T cells and protects against both typhoidal and non-typhoidal Salmonella serovars

Association between immune checkpoint inhibitor medication and uveitis: a population-based cohort study utilizing TriNetX database

Impact of structural modifications of IgG antibodies on effector functions

Transmission characteristics and inactivated vaccine effectiveness against transmission of the SARS-CoV-2 Omicron BA.2 variant in Shenzhen, China

Immunogenicity, safety and consistency of seven lots of an inactivated COVID-19 vaccine in healthy children and adolescents: a randomized, double-blind, controlled, phase IV clinical trial

Humoral and cell-mediated immune responses in HIV-vertically infected young patients after three doses of the BNT162b2 mRNA SARS-CoV-2 vaccine

Humoral and cellular immune responses after COVID-19 vaccination of lung transplant recipients and patients on the waiting list: a 6-month follow-up

Refined innate plasma signature after rVSVΔG-ZEBOV-GP immunization is shared among adult cohorts in Europe and North America

Evaluation of the efficacy, safety and influencing factors of concomitant and sequential administration of viral respiratory infectious disease vaccines: a systematic review and meta-analysis

Contribution of SARS-CoV-2 infection preceding COVID-19 mRNA vaccination to generation of cellular and humoral immune responses in children

Evaluation of the humoral and mucosal immune response of a multiepitope vaccine against COVID-19 in pigs

The PRotective Effect of Maternal Immunisation on preTerm birth: characterising the Underlying mechanisms and Role in newborn immune function: the PREMITUR study protocol

Appearance of tolerance-induction and non-inflammatory SARS-CoV-2 spike-specific IgG4 antibodies after COVID-19 booster vaccinations

Non-glycosylated G protein with CpG ODN provides robust protection against respiratory syncytial virus without inducing eosinophilia